OK-101

Indication
Preclinical
IND
Phase 1
Phase 2
Phase 3

Dry Eye Disease (DED)

Phase 2 trial completed

Phase 2 trial completedPhase 2

Neuropathic Corneal Pain (NCP)

Plan to open trial in Q3 2024

Plan to open trial in Q3 2024Phase 1

Allergic Conjunctivitis

Preclinical

Uveitis

Preclinical

OK-201

Indication
Preclinical
IND
Phase 1
Phase 2
Phase 3

Discovery Program